Li Juan

20PUBLICATIONS

21CO-AUTHORS

Medical virologyMedical mycologyPredictive and prognostic markersMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (20)

Sort by Publication Date:

|Jun 12, 2026

Clinical implications and predictors of MRD resurgence in ASCT-eligible patients with NDMM: a real-world study in China.

|May 27, 2026

Sustained MRD Negative for 4 Years Is a Significant Marker of Prognosis in Patients with High-Risk Multiple Myeloma.

|May 10, 2026

Outcomes Among MM Patients Receiving Early Intervention for MRD Progression Following Autologous Stem Cell Transplantation.

|Nov 03, 2025

Impact of early minimal residual disease assessment on the outcomes of patients with systemic light chain amyloidosis.

Xiaozhe Li, Meilan Chen, Junru Liu

|Aug 01, 2025

The bone marrow immune ecosystem shapes daratumumab acquired resistance in plasma cell myeloma.

Yun Wang, Shuzhao Chen, Zhijian Liang

|Jan 25, 2025

Early Identification of the Non-Transplanted Functional High-Risk Multiple Myeloma: Insights from a Predictive Nomogram.

Yanjuan Li, Lifen Kuang, Beihui Huang

Pageof 4

Frequent Collaborators

Junru Liu

Yuan Jian

Juan Du

Zhiyao Zhang

Yin Wu

Weida Wang

Yang Liang

Yanjuan Li

Beihui Huang

Han-Ying Huang

Frequent Collaborators

Junru Liu

Yuan Jian

Juan Du

Zhiyao Zhang